Jordan Denizeau

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies.

A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies.

Journal: Frontiers in immunology
Published: October 22, 2025

Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.

Argonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancer.

Journal: PLoS biology
Published: September 05, 2025

CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance.

CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance.

Journal: Oncoimmunology
Published: May 12, 2025

Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.

Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.

Journal: Nature communications
Published: May 30, 2023

CD74 supports accumulation and function of regulatory T cells in tumors.

CD74 supports accumulation and function of regulatory T cells in tumors.

Journal: Nature communications
Published: March 28, 2023

Selective STING stimulation in dendritic cells primes antitumor T cell responses.

Selective STING stimulation in dendritic cells primes antitumor T cell responses.

Journal: Science immunology
Published: January 13, 2023

Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.

Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodes.

Journal: Oncoimmunology
Published: April 04, 2022

CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.

CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.

Journal: Nature communications
Published: December 08, 2020

Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer.

Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer.

Journal: Cell
Published: November 16, 2020

IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation.

IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation.

Journal: Cancer immunology research
Published: October 01, 2018

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.

Journal: Nature biotechnology
Published: August 02, 2018

Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node.

Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node.

Journal: Nature communications
Published: July 24, 2017
Showing 1-12 of 14

Last Updated: 09/26/2026